Abstract

Drug utilization of biological drugs in the treatment of chronic Immune-Mediated Inflammatory Diseases (IMIDs): an observational study on Italian patients

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Letter from the Editor: Cost-effectiveness of tuberculosis screening in patients already on biologic therapy
Dirk M Elston
Journal of the American Academy of Dermatology | VOL. 87
Dirk M ElstonDirk M Elston
26 May 2022
Role of Microparticles in the Pathogenesis of Inflammatory Joint Diseases.
Magdalena Krajewska-Włodarczyk ... Agnieszka Owczarczyk-Saczonek
International Journal of Molecular Sciences | VOL. 20
Magdalena Krajewska-Włodarczyk, et. al.Magdalena Krajewska-Włodarczyk ... Agnieszka Owczarczyk-Saczonek
01 Nov 2019
COVID-19 vaccination of patients with chronic immune-mediated inflammatory disease
Wen Yanfang ... Wang Yan
Advances in Rheumatology | VOL. 63
Wen Yanfang, et. al.Wen Yanfang ... Wang Yan
01 Nov 2023
Efficacy and safety of etanercept in chronic immune-mediated disease
Giuseppe Murdaca ... Francesco Puppo
Expert opinion on drug safety | VOL. 13
Giuseppe Murdaca, et. al.Giuseppe Murdaca ... Francesco Puppo
22 Mar 2014
View more papers

More From: Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish

Paper Title
Journal
Date
Author
Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview
Rosario Cultrera
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish | VOL. -
Rosario CultreraRosario Cultrera
29 Jul 2024
Usefulness of dalbavancin in early discharge and non-hospitalization. It’s time to throw your heart over the obstacle?
Massimo Crapis ... Barbara Basso
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish | VOL. 11
Massimo Crapis, et. al.Massimo Crapis ... Barbara Basso
29 Jul 2024
The efficacy of dalbavancin and impact on hospitalization and treatment costs in patients with ABSSSI
Sergio Carbonara
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish | VOL. -
Sergio CarbonaraSergio Carbonara
29 Jul 2024
Clinical pharmacy and telemedicine: an opportunity to improve epilepsy management.
Rossella Moscogiuri
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish | VOL. 11
Rossella MoscogiuriRossella Moscogiuri
22 Jul 2024
View more papers